Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 11, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the registrant.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of shareholding changes rather than a financial performance report.
Material Changes
The filing details a change in the number of Ordinary Share ADRs held by the GlaxoSmithKline US Retirement Savings Plan ("the Plan").
- Date of Movement: August 10, 2006
- Previous Holding: 17,443,903 ADRs
- New Holding: 17,403,364 ADRs
- Average Price: $53.89
- Reason: Movement in the fund.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the Plan is a discretionary fund for employees and former employees, and that Directors Dr. J.P. Garnier and Dr. M.M. Slaoui are potentially interested in the shares held in the fund in the same manner as other employees.
Investor Verification Points
- Verify the impact of the fund movement on the total share count held by the US Retirement Savings Plan.
- Confirm the potential interest of Directors Dr. J.P. Garnier and Dr. M.M. Slaoui in the fund's holdings.
- Note that this filing does not contain financial performance data; refer to Form 20-F for comprehensive financial metrics.